Repare Therapeutics Inc. (RPTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 55.56M |
| Enterprise Value | -27.23M |
| P/E Ratio | -2.59 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 9.62 |
| Price/Book Ratio | 0.99 |
| Enterprise/Revenue | 3.52 |
| Enterprise/EBITDA | -0.87 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -3.67 |
| Operating Margin | -3.74 |
AD
Management Effectiveness
| Return On Assets | -0.34 |
| Return On Equity | -0.37 |
Income Statement
| Revenue | 53.48M |
| Revenue/Share | 0.28 |
| Gross Profit | 40.1M |
| EBITDA | -90.22M |
| Net Income | -84.69M |
| Diluted EPS | -2 |
Balance Sheet
| Total Cash | 112.6M |
| Total Cash/Share | 2.62 |
| Total Debt | 342,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.71 |
| Book Value Per Share | 2.68 |
Price History
| 52-Week Change | 120.83 |
| 52-Week High | 2.66 |
| 52-Week Low | 0.89 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 1.75 |
Statistics
| Average Volume | 1.18M |
| Shares Outstanding | 43.11M |
| % Held by Institutions | 58.57 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
